Recorded Chinese product: 地塞米松植入剂地塞米松植入剂

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

地塞米松是一种在国家药监局注册认定的药品。该药品含有地塞米松-a4207ab1等成分。

该药品关联的活性成分包括:地塞米松Disai Misong。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:华润紫竹药业有限公司Chinese legal name: 华润紫竹药业有限公司。

您可以探索含有相同成分的其他药品:地塞米松-a4207ab1成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 地塞米松植入剂) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 地塞米松Disai Misong.

Manufacturers recorded for this product: 华润紫竹药业有限公司Chinese legal name: 华润紫竹药业有限公司.

Explore other medicines containing the same ingredient: 地塞米松 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 地塞米松植入剂Recorded Chinese product: 地塞米松植入剂
  • 剂型Dosage form: 植入剂Implant
  • 规格Specification: 0.06mg0.06 mg

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 华润紫竹药业有限公司Chinese legal name: 华润紫竹药业有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H19990351

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H19990351

Manufacturer

Chinese legal name: 华润紫竹药业有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H19990351

生产企业

华润紫竹药业有限公司(国产)

适应症

适用于由于白内障摘除并植入人工晶体后引起的术后眼内炎症。

用法用量

在眼科手术结束并取出粘弹物质后,用精密无齿镊从包装中取出本品一粒放入眼前房或后房。如果放在前房,应将药料放在12点虹膜基底位置;如果放在后房,应放在虹膜和人工晶体前表面之间的6点位置,然后以常规方式闭合切口。本品在使用前和使用时必须处于无菌状态,除非立即使用本品,其他任何时候不应该打开锡箔包装。

不良反应

在临床试验中没有发现与植入本品直接有关的系统性的不良反应和局部刺激作用。本品一般不会引起眼压升高,因个体差异,偶可出现眼压升高,但均为可逆性,用药后即可恢复正常

禁忌

1、有单纯疱疹性角膜炎、水痘和其它角膜和结膜的病毒性疾患者; |2、分枝杆菌感染患者; |3、眼组织真菌疾病患者; |4、青光眼患者或有青光眼家庭史的患者; |5、对肾上腺皮质激素类药有过敏史者。

注意事项

1、本品只能由有资格的眼科手术医生使用。||2、本品的内外包装只允许在临用前而且是在无菌手术室内方可拆开。||3、在临床研究中没有发现在植入本品时应特别的注意事项。

贮藏

遮光,严封保存。

规格

0.06mg

证据Evidence

  • 批准文号: 国药准字H19990351
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.